Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Shares Issued (2016 - 2025)

Wave Life Sciences' Shares Issued history spans 11 years, with the latest figure at -$2.2 million for Q3 2025.

  • For Q3 2025, Shares Issued fell 479.65% year-over-year to -$2.2 million; the TTM value through Dec 2025 reached $881000.0, up 33.69%, while the annual FY2025 figure was $881000.0, 33.69% up from the prior year.
  • Shares Issued reached -$2.2 million in Q3 2025 per WVE's latest filing, down from $2.6 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $51.3 million in Q2 2022 to a low of -$37.2 million in Q3 2022.
  • Average Shares Issued over 5 years is $161666.7, with a median of $255000.0 recorded in 2021.
  • The largest YoY upside for Shares Issued was 37813.24% in 2022 against a maximum downside of 9215.69% in 2022.
  • A 5-year view of Shares Issued shows it stood at -$358000.0 in 2021, then tumbled by 3782.68% to -$13.9 million in 2022, then skyrocketed by 105.38% to $748000.0 in 2023, then plummeted by 134.76% to -$260000.0 in 2024, then crashed by 732.31% to -$2.2 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Shares Issued are -$2.2 million (Q3 2025), $2.6 million (Q2 2025), and $442000.0 (Q1 2025).